Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
oncolytic
Press Release
Jul 19, 2016
Cancer Virotherapy Medicine Received the Grant From European Commission in Order to Initiate the Commercialization in the EU Markets
Read More
Press Release
Jul 14, 2016
World Boxing Champion Mairis Briedis Joins Cancer Fighting Team
Read More
Press Release
Jul 19, 2010
Oncolytics Biotech® Inc. Receives No Objection Letter from Health Canada to Conduct Phase 3 Trial of REOLYSIN® in Head and Neck Cancers
Oncolytics Biotech Inc announced that it has received a No Objection Letter from Health Canada to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin.
Read More
First
Prev
1
Next
Last
